Please assess the completion status of the following clinical trial:

Trial Title: ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria :~* Postmenopausal ambulatory women~* Established osteoporosis~Exclusion criteria:~* History of cancer: basal cell or squamous cell carcinoma-documented 6-month remission,~* Diagnosis of hypocalcemia, hyperparathyroidism, hyperthyroidism~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: FEMALE
- Minimum Age: 55 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).